TNFRSF1B and breast cancer: Supporting this notion, in a study including 125 patients with primary BC, a significant association was shown between TNFR2 and worse outcomes, such as increased tumor size, a more advanced clinical stage, a higher pathological grade, reduced OS, and DFS [298].